Market Place
Sourcing Support
Enforcement Report - Week of September 6, 2023
06 Sep 2023 //
FDA
Enforcement Report - Week of August 9, 2023
09 Aug 2023 //
FDA
GENIXUS Announces Launch of KinetiXTM Rocuronium Bromide Injection
03 Aug 2023 //
BUSINESSWIRE
Fresenius Kabi Launches RFID-Enabled Rocuronium Bromide Injection
30 May 2023 //
BUSINESSWIRE
Enforcement Report - Week of January 18, 2023
18 Jan 2023 //
FDA
Piramal Critical Care Launches First to Market Generic Zinc Sulfate Injection in the U.S.
19 Aug 2022 //
PRNEWSWIRE
Enforcement Report - Week of June 8, 2022
08 Jun 2022 //
FDA
Hameln has received certificate “Union Format for Registration of Manufacturer
03 Jan 2022 //
PRESS RELEASE
Enforcement Report- Week of October 27, 2021
27 Oct 2021 //
FDA
Rocuronium bromide solution for injection 10mg/mL, Hameln, and reports of lack
31 Jul 2020 //
GOVT
Wavelength Expands Supplies of Key Drug Ingredients for Critically Ill COVID-19
20 Apr 2020 //
BIOSPACE
Wavelength Ups API Production for Essential Respiratory Meds
20 Apr 2020 //
CONTRACTPHARMA
Camargo Pharma`s Generic Rocuronium Bromide Receives Approval in US
19 Aug 2019 //
FDA
Medicines Safety Update, Volume 9, Number 3, August-September 2018
17 Sep 2018 //
TGA
Gland Chem`s Generic Rocuronium Bromide Receives Approval In US
06 Apr 2018 //
FDA
FDA Issues Form 483 to SCA Pharmaceuticals (Outsourcing Facility)
29 Mar 2018 //
FDA
Enforcement Report - Week of February 28, 2018
28 Feb 2018 //
FDA
Enforcement Report - Week of November 8, 2017
08 Nov 2017 //
FDA
SCA Pharmaceuticals Issues Voluntary Nationwide Recall of Specific Products
21 Oct 2017 //
FDA
Enforcement Report - Week of August 16, 2017
16 Aug 2017 //
FDA
West Ward Pharm’s Generic Rocuronium Bromide Receives Approval In US
02 Mar 2017 //
FDA
Gland Chemicals Receives Written Confirmation of Export of 3 APIs to EU
20 Jan 2016 //
TWOFOUR INSIGHT
At long last, Merck gets FDA panel backing for Bridion
10 Nov 2015 //
PM LIVE
Dutch pension fund pulls out of Mylan amid death penalty drug concerns
31 Aug 2015 //
FIERCE PHARMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.